Abstract
The nuclear factor κB (NF-κB) is a superfamily of transcription factors. It plays an important role in development & progression of cancer. This study was conducted in a tertiary care centre to investigate the significance of NF-κB as a prognostic marker in breast cancer and study its relation with established prognostic markers such as tumor grade, lymph node status, hormone receptor & HER-2/neu expression. We measured NF-κB expression of breast cancer tissue as a test sample & from fibroadenoma as a control. Measurement was done by Western Blot Technique using p65 protein of NF-κB super family of transcription factors. ER,PR and HER-2/neu were measured by immunohistochemistry methods. NF-κB/p65 is significantly associated with large tumor size (≥5 cm), high grade tumors, negative ER, negative PR, positive HER-2/neu and high NPI (≥5.4) scores. NF-κB/p65 expression implies aggressive biological behaviour of breast cancer & this study validates significant association of NF-κB /p65 overexpression with large tumor size, negative estrogen & progesterone receptor status and overexpression of c-erbB2 oncoprotein.
Similar content being viewed by others
References
Chen LF, Greene WC (2004) Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol 5:392–401
Radhakrishnan SK, Kamalakaran S (2006) Pro-apoptotic role of NF-κB: implications for cancer therapy. Biochim Biophys Acta 1766:53–62
Greten FR, Karin M (2004) The IKK/NF-kB activation pathway—a target for prevention. Cancer Lett 206:193–199
Van Laere SJ, Van der Auwera I, Van den Eynden GG, van Dam P, Van Marck EA, Vermeulen PB, Dirix LY (2007) NF-kB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation. Br J Cancer 97:659–669
Shostak K, Chariot A (2011) Breast Cancer Res 13:214
Ali S, Coombes C (2002) Nat Rev Mol Cell Biol 2:101–115
Kalkhoven E, Wissink S, van der Saag PT, van der Burg B (1996) J Biol Chem 271:6217–6224
Merkhofer EC, Cogswell P, Baldwin AS (2010) Her2 activates NF-κB and induces invasion through the canonical pathway involving IKKα. Oncogene 29:1238–1248
Sethi G, Sung B, Aggarwal BB (2008) Nuclear factor-κB activation: from bench to bedside. Exp Biol Med 233:21–31
Zhou Y, Eppenberger-Castori S, Eppenberger U, Benz CC (2005) The NF-κB pathway and endocrine-resistant breast cancer. Endocr Relat Cancer 12:S37–S46
Zhoua Y, Eppenberger-Castorib S, Marxa C, Yaua C, Scotta GK, Eppenbergerb U, Benz CC (2005) Activation of nuclear factor-κB (NF-κB) identifies a high-risk subset of hormone-dependent breast cancers. Int J Biochem Cell Biol 37:1130–1144
Biswas DK, Cruz AP, Gansberger E, Pardee AB (2000) Epidermal growth factor-induced nuclear factor kB activation: a major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells. PNAS 97(15):8542–8547
Nakshatri H, Bhat-Nakshatri P, Martin DA, Gouet RJ Jr, Sledge GW Jr (1997) Constitutive activation of NF-kB during progression of breast cancer to hormone-independent growth. Mol Cell Biol 17(7):3629–3639
Hou M-F, Lin S-B, Yuan S-SF, Tsai S-M, Wu S-H, Ou-Yang F, Hsieh J-S, Tsai K-B, Huang T-J, Tsai L-Y (2003) The clinical significance between activation of nuclear factor kappa B transcription factor and overexpression of HER-2/neu oncoprotein in Taiwanese patients with breast cancer. Clin Chim Acta 334:137–144
Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357(9255):539–545
Karin M, Lin A (2002) NF-kappaB at the crossroads of life and death. Nat Immunol 3:221–227
Biswas DK, Martin KJ, McAlister C, Cruz AP, Graner E, Dai SC, Pardee AB (2003) Apoptosis caused by chemotherapeutic inhibition of nuclear factor-kappaB activation. Cancer Res 63:290–295
Biswas DK, Dai S-C, Cruz A, Weiser B, Graner E, Pardee AB (2001) The nuclear factor kappa B (NF-kB): a potential therapeutic target for estrogen receptor negative breast cancers. PNAS 98:10386–10391
Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet RJ Jr, Sledge GW Jr (1997) Constitutive activation of NFkappaB during progression of breast cancer to hormone-independent growth. Mol Cell Biol 17:3629–3639
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sarkar, D.K., Jana, D., Patil, P.S. et al. Role of NF-κB as a Prognostic Marker in Breast Cancer : A Pilot Study in Indian Patients. Indian J Surg Oncol 4, 242–247 (2013). https://doi.org/10.1007/s13193-013-0234-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13193-013-0234-y